NHP Stroke Study

aldric-hama
Mar 17, 2020
1 min read

Updated: Apr 21, 2021

Announcing Astrocyte Pharmaceuticals' efficacy study of AST-004 in a NHP model of stroke! For more details, click here

Recent Posts

Notice Regarding Organizational Restructuring of Group Companies

We hereby announce that our subsidiaries, CMIC Pharma Science Co., Ltd. (Head Office: Hokuto City, Yamanashi Prefecture; President & CEO: Takahiro Natsume; hereinafter “CMIC Pharma Science”) and Hamam

Announcement of an Alliance for Preclinical and Early Clinical Research and Trials in the Development of Radiopharmaceuticals in Japan

Hamamatsu Pharma Research is pleased to announce that our company, in collaboration with Hakuto Co., Ltd. and Samurai Imaging Partners Co., Ltd., has launched the “Radiopharmaceutical Drug Discovery S

HPR Presenting at the SOT, San Diego 2026

Comments